title: Successful results of a bipolar active fixation lead for atrial application: an interim analysis.
abstract: Adequate atrial lead performance consists of stable sensing and pacing properties. To evaluate whether the CPI 4269 bipolar lead, covered with mannitol (Sweet Tip), in the atrial position encounters these properties, we performed a prospective study of this lead. After complete dissolution of the mannitol helix, mapping of the atrium to obtain the highest electrogram and lowest threshold was followed by screw-in into the endocardium. Intraoperative measurements were performed and long-term follow-up was scheduled every 6 to 12 months to measure threshold and perform an intracardial electrogram. Between February 1993 and December 1996, a total number of 73 leads in the atrial position in a consecutive series of patients was implanted. Implantation was performed in 28 patients receiving an AAIR and 45 patients a DDDR pacemaker. Reason for pacemaker implantation was a third-degree AV block in 37% of patients, type II second-degree AV block in 25%, sick sinus syndrome in 35%, and drug refractory paroxysmal atrial fibrillation following His-bundle ablation in 3%. The intraoperative bipolar atrial electrogram had a mean voltage of 4.25 +/- 2.1 mV. The acute atrial bipolar threshold was 0.63 +/- 0.43 V, and current was 1.35 +/- 0.81 mA at a 1.0-ms pulse duration. The mean acute resistance of the lead was 572 +/- 86 Ohm. After a mean follow-up of 18.3 months, the bipolar intracardial electrogram was 3.37 +/- 2.00 mV, the mean atrial threshold measured at the last outpatient clinic visit was 0.99 +/- 0.74 V and the mean impedance was 640 +/- 127 Ohm. A sensing problem due to traction of the atrial lead occurred in only one patient. Acute and late dislodgement did not occur. The CPI 4269 (Sweet Tip) lead is manufactured with a dissolvable capsule covering the helix tip electrode, permitting a safe passage through the venous system. This interim analysis shows that this lead in the atrial position has favorable acute and chronic results.
authors.affiliation: Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.
authors.forename: E M
authors.initials: EM
authors.lastname: Buys
authors.forename: N M
authors.initials: NM
authors.lastname: Van Hemel
authors.forename: E R
authors.initials: ER
authors.lastname: Jessurun
authors.forename: B
authors.initials: B
authors.lastname: Poot
authors.forename: J C
authors.initials: JC
authors.lastname: Kelder
authors.forename: J J
authors.initials: JJ
authors.lastname: Defauw
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001145:Arrhythmias, Cardiac / Q000503:physiopathology / Q000628:therapy*; D018780:Body Surface Potential Mapping; D006328:Cardiac Catheterization; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D020099:Coated Materials, Biocompatible; D004567:Electrodes, Implanted; D004867:Equipment Design; D005260:Female; D006325:Heart Atria / Q000503:physiopathology; D006801:Humans; D007495:Iridium; D008297:Male; D008353:Mannitol; D008875:Middle Aged; D010138:Pacemaker, Artificial; D010984:Platinum; D011446:Prospective Studies; D012826:Silicone Elastomers; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D020099:Coated Materials, Biocompatible; D012826:Silicone Elastomers; D008353:Mannitol; D007495:Iridium; D010984:Platinum